ROCHESTER, Minn. — Mayo Clinic transplant researchers will present findings from nearly 20 studies at the American Transplant Congress in Philadelphia, Penn., May 2-5.
Mayo Clinic is nationally recognized for research and clinical success in transplantation, and performs over 1,000 solid organ transplants each year. Researchers will share findings from the following late-breaking studies at the American Transplant Congress:
“Burden of Early Antibody-Mediated Rejection (AMR): Complications, Resource Utilization and Cost Differential in Treatment of AMR”
This study examined the connection between early AMR (a situation following transplant surgery in which the body begins to reject the donor organ) and clinical complications, hospital resource utilization and related costs.
An examination of 48 adult patients with AMR found those who were diagnosed with early AMR experienced higher rates of complications, almost double the number of hospital days and surgical procedures, and significantly higher post-transplant health care costs.
Mayo Clinic researchers involved in this study include Ramandeep Banga, MBBS, Carrie Schinstock, M.D., Matthew Hathcock, Walter Kremers, Ph.D., and Mark Stegall, M.D.
Presentation Date: May 2, 5:30 p.m. to 7:30 p.m. EDT
MEDIA CONTACT: Ginger Plumbo, Mayo Clinic Public Affairs, 507-284-5005, Email: firstname.lastname@example.org.